Futura Medical

Update in progress

FUM.L (LSE)

Company RatingNeutral
SectorHealthcare
IndustryBiotechnology

Futura Medical plc is a pharmaceutical company that researches, develops, and commercializes products for sexual health. Its lead product is Eroxon, a topical gel for erectile dysfunction. It is developing WSD4000 for female sexual dysfunction. The company operates in the UK, the EU, the US, and internationally. Incorporated in 2001, Futura Medical is headquartered in Guildford, United Kingdom.

Company score

Sentiment: -0.34; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.18; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: -0.04; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.04; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: -0.15; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive